Log in to save to my catalogue

FDA Emergency Use Authorization From 9/11 to COVID-19: Historical Lessons and Ethical Challenges

FDA Emergency Use Authorization From 9/11 to COVID-19: Historical Lessons and Ethical Challenges

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_jstor_primary_27091369

FDA Emergency Use Authorization From 9/11 to COVID-19: Historical Lessons and Ethical Challenges

About this item

Full title

FDA Emergency Use Authorization From 9/11 to COVID-19: Historical Lessons and Ethical Challenges

Author / Creator

Publisher

Food and Drug Law Institute (FDLI)

Journal title

Food and drug law journal, 2021-01, Vol.76 (2), p.337-380

Language

English

Formats

Publication information

Publisher

Food and Drug Law Institute (FDLI)

More information

Scope and Contents

Contents

Emergency use authorization (EUA) is a power granted by Congress to FDA to expedite the availability and distribution of medical countermeasures during public health emergencies. This Article reviews the history of FDA’s EUA authority from its inception in the post-9/11 era to its present-day use in response to COVID-19 in order to better understan...

Alternative Titles

Full title

FDA Emergency Use Authorization From 9/11 to COVID-19: Historical Lessons and Ethical Challenges

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_jstor_primary_27091369

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_jstor_primary_27091369

Other Identifiers

ISSN

1064-590X

How to access this item